ABUS
ABUS
CA03879J1003
Arbutus Biopharma Corporation
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 14.083.000 6.171.000
128.2%
Cost of Revenue -- --
--
Gross Profit -- --
--
41.134.000 76.145.000
46.0%
Operating Income -27.051.000 -69.974.000
61.3%
Pretax Income -33.501.000 -69.920.000
52.1%
Net Income Common Stockholders -33.501.000 -69.920.000
52.1%
-- --
--
-- --
--
ende